Biomedical applications and potential health risks of nanomaterials: molecular mechanisms.
By S. Lanone, J. Boczkowski. Current molecular medicine, 2006
433 citations recorded by the source corpus.
Subfields: Materials Chemistry
View Paper: https://www.semanticscholar.org/paper/bb973c6de87097cf20d2d95ac723df5b9326132a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Materials Chemistry
Citations in the corpus
- Silver Nanoparticles as Potential Antiviral Agents (2011, background): “, NFκB), activator protein-1, and kinases involved in inflammation [94,95,96,97].”
- Effects of nanomaterial physicochemical properties on in vivo toxicity (2009, positive): “Free radicals can originate from several sources including phagocytic cell response to foreign material, insufficient amounts of anti-oxidants, presence of transition metals, environmental factors, and, as focused in this review, physicochemical properties of some nanomaterials [3].”
- Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications (2010, background): “After gaining access to the circulatory system, nanoparticles can be distributed throughout the body and to specific organs [34,35], and taken up by cells through phagocytic or endocytic mechanisms [18].”
- Nanotoxicology and in vitro studies: the need of the hour. (2012, background): “…studies highlight the need for undertaking further investigations on the antigenicity (capacity to evoke immune response) of nanoparticles per se and their complexes (with cellular biomolecules) as well as the resulting specific immune responses (Curtis et al., 2006; Lanone and Boczkowski, 2006).”
- Nanotechnology and Water Treatment: Applications and Emerging Opportunities (2008, background): “Several hypotheses concerning physiochemical characteristics of nanoparticles responsible for adverse health effects have been proposed (Lanone and Boczkowski 2006; Nel et al. 2006; Maynard 2007).”
- Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles (2007, background): “Presently, to better understand the potentially harmful side effects of nanomaterials, many nanobiologists call for an extensive investigation of nanotoxicological issues.(90,92,93) For instance, Qdots are good nanoprobes and are useful for in vivo biomedical imaging of cancer in animal models, but ”